Sign in

CIK 0001806952

  • Non-accelerated filer
  • Smaller reporting company

Lyell Immunopharma, Inc.

Sign in to watch
Ticker
LYEL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
833006753
Phone
+1 650-695-0677
Business address
201 HASKINS WAY, SOUTH SAN FRANCISCO, CA, 94080
Open-market buys, last 90 days
$49,999,983
in 2 filings
Open-market sales, last 90 days
$28,757
in 6 filings

Net +$49,971,226. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-09-10 Shook David Chief Medical Officer Sale −500 $12.70 $6K 20,423
2026-06-10 Shook David Chief Medical Officer Sale −1,977 $12.64 $25K 20,923
2026-02-10 Shook David Chief Medical Officer Grant or award · Option (right to buy) +50,000 50,000
2025-06-09 Shook David Chief Medical Officer Grant or award +21,900 21,900
2025-06-09 Shook David Chief Medical Officer Grant or award · Option (right to buy) +43,750 43,750

Page 1 of 1 · 5 trades